{"schema_version":"secwatch.filing_event.v1","accession":"0001079973-26-000611","form_type":"8-K","ticker":"TOI","cik":"0001799191","company_name":"Oncology Institute, Inc.","filed_at":"2026-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.926291+00:00","generated_at":"2026-05-14T21:57:44.403901+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"confidence":"high","headline":"TOI Q1 revenue up 41% to $147.4M, net loss narrows to $2.5M","bullets":["Revenue $147.4M (+41% YoY); net loss $2.5M vs $19.6M loss prior year.","Adjusted EBITDA loss $2.4M improved from $5.1M loss; EPS $(0.02) vs $(0.21).","Specialty Pharmacy revenue up 78% YoY; record Part D fills.","Medicare Advantage lives to reach 200,000 in Florida effective July 1, 2026.","CMS Enhancing Oncology Model saved ~$2M in period 3; full-year guidance reaffirmed."],"urls":{"canonical":"https://secwatch.observer/filing/0001079973-26-000611","json":"https://secwatch.observer/filing/0001079973-26-000611.json","markdown":"https://secwatch.observer/filing/0001079973-26-000611.md","text":"https://secwatch.observer/filing/0001079973-26-000611.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000611/0001079973-26-000611-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000611/toi_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T21:57:44.403901+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}